Biogen Inc. (BIIB)

Last Closing Price: 215.63 (2024-03-28)

Income from Continuous Operations (Quarterly)

Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.

Biogen Inc. (BIIB) had Income from Continuous Operations of $248.90M for the most recently reported fiscal quarter, ending 2023-12-31.

Figures for fiscal quarter ending 2023-12-31
Income Statement Financials
$2.39B
$249.70M
$618.30M
$1.77B
$2.03B
$358.90M
$-67.30M
$291.60M
$291.60M
$248.90M
Income from Continuous Operations
$248.90M
$248.90M
$248.90M
$358.90M
$530.50M
144.70M
145.60M
$1.71
$1.70
Balance Sheet Financials
$6.86B
$3.31B
$19.99B
$26.84B
$3.43B
$6.79B
$8.61B
$12.05B
$14.80B
$217.20M
$14.80B
144.90M
Cash Flow Statement Financials
$1.55B
$-4.10B
$149.30M
$3.42B
$1.05B
$-2.37B
$264.20M
--
--
Fundamental Metrics & Ratios
2.00
--
--
0.31
0.47
74.09%
15.04%
15.04%
--
12.22%
10.46%
$1.27B
--
--
--
0.09
0.24
1.43
62.76
1.68%
114.59%
0.93%
1.15%
$102.14
$8.72
$10.63